BD reports 5.2% revenue growth, raises full-year EPS guidance after strong Q2 results

BD (Becton, Dickinson and Company) reported a 5.2% increase in revenue to $4.7 billion for its fiscal Q2 2026, driven by broad-based growth across its business segments. The company executed a $2 billion share repurchase and retired $2.1 billion in debt, reflecting strong capital management. BD raised its full-year adjusted diluted EPS guidance, citing solid execution and ongoing margin improvements. Key product launches and strategic partnerships in medical technology and connected care support BD's growth outlook.